BIOLON Trademark

Trademark Overview

On Thursday, April 25, 2024, a trademark application was filed for BIOLON with the United States Patent and Trademark Office. The USPTO has given the BIOLON trademark a serial number of 98518501. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, February 17, 2026. This trademark is owned by Ferring B.V.. The BIOLON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in ocular or intraocular surgery
biolon

General Information

Serial Number98518501
Word MarkBIOLON
Filing DateThursday, April 25, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, February 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in ocular or intraocular surgery

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFerring B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp NL-2132 JX
NL
Party NameFerring B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp NL-2132 JX
NL

Trademark Events

Event DateEvent Description
Thursday, April 25, 2024NEW APPLICATION ENTERED
Thursday, April 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 1, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 7, 2024ASSIGNED TO EXAMINER
Friday, August 9, 2024NON-FINAL ACTION WRITTEN
Friday, August 9, 2024NON-FINAL ACTION E-MAILED
Friday, August 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 10, 2025SOU TEAS EXTENSION RECEIVED
Monday, March 10, 2025SOU EXTENSION 1 FILED
Monday, March 10, 2025SOU EXTENSION 1 GRANTED
Tuesday, March 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 17, 2026SOU TEAS EXTENSION RECEIVED
Tuesday, February 17, 2026SOU EXTENSION 2 FILED
Tuesday, February 17, 2026SOU EXTENSION 2 GRANTED
Saturday, February 28, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

biolon surgery intraocular ocular preparations pharmaceutical